1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

Epiomic Epidemiology Series: Ovarian Cancer Forecast in 17 Major Markets 2015-2025

  • September 2015
  • 50 pages
  • Black Swan Analysis Ltd
Report ID: 3791810

Summary

Table of Contents

Search Inside

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ovarian Cancer in 17 Major Markets

Ovarian Cancer begins in the ovaries, resulting from abnormal cells that have the ability to spread to other parts of the reproductive system and, in advanced stages, other parts of the body. The cause for Ovarian Cancer is not currently known, most DNA mutations for ovarian cancer are acquired genetic changes, however a link still has not yet been found to any environmental factors that may cause the mutation. This report provides the current incidence population for Ovarian Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Australia, Canada, Mexico, Turkey, South Africa, Saudi Arabia, Argentina and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, grades and associated Charlson Co-morbidity scoring of Ovarian Cancer. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ovarian Cancer have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Ovarian Cancer include:

-Diabetes
-Myocardial Infarct
-Mild Liver Disease
-Congestive Heart Failure
-Dementia

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Ovarian Cancer’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of Ovarian Cancer and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Ovarian Cancer’s prevalent population.
-Identify sub-populations within Ovarian Cancer which require treatment.
-Gain an understanding of the specific markets that have the largest number of Ovarian Cancer patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: BRCA 1 & 2 Mutation in Cancer Forecast in 18 Major Markets 2017-2027

  • $ 6859
  • Industry report
  • June 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on BRCA1 and BRCA2 mutation in Cancer in 18 Major Markets It has long been established that BRCA1 and BRCA2 (BReast CAncer susceptibility ...

Brenner Tumor Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • May 2017
  • by GlobalData

Brenner Tumor Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2017" provides an overview of Brenner Tumor clinical ...

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017

  • $ 2995
  • Industry report
  • September 2017
  • by Currentpartnering

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering ...

Global Alpha Emitters Market

July 2017 $ 4250

Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Ovarian Cancer

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.